Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.
Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.
Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework.
Journey to multi-million dollar Amgen acquisition required curiosity, collaboration and commercial expertise
--CWRU Daily, April 8, 2021
Case Western Reserve University biotech startup Rodeo Therapeutics Corp. sold to Amgen Inc.
--CWRU Daily, March 31, 2021
Amgen to Acquire Rodeo Therapeutics Corporation
--PRNewswire, March 30, 2021
--NervGen March 8, 2021
Please visit our TTO News webpage for more articles and press releases about TTO success stories.
For Questions About...
- Your Invention Disclosure Form (IDF), please contact Joy Chen at 216.368.0362.
- A Material Transfer Agreement (MTA) please contact Walid Jalabi at 216.368.2151.
- A Data Use Agreement (DUA), please contact Courtney Pokorny at 216.368.0336
- Anything else, please contact Daniel Pendergast at 216.368.0184.